Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles

4 Feb 2023

Abstract excerpt

BACKGROUND: While anti-Müllerian hormone (AMH) predicts quantitative IVF outcomes such as oocyte yield, it is not certain whether AMH predicts markers of oocyte quality such as aneuploidy. METHODS: Retrospective case-control analysis of the SART-CORS database, 2014-2016, to determine whether anti-Müllerian hormone (AMH) predicts aneuploidy and live birth in IVF cycles utilizing preimplantation genetic testing for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Ovarian function and disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36739415
DOI: 10.1186/s12958-023-01066-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cyclesPMID 36739415Read ↗

High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndromeSemantic proximity Read ↗

Diminished ovarian reserve is associated to euploidy rate: a single center studySemantic proximity Read ↗

Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018Semantic proximity Read ↗

Maternal Antimüllerian Hormone as a Predictor of Euploid Is Independently Associated With Cumulative Live Birth RatesSemantic proximity Read ↗

The number and rate of euploid blastocysts in women undergoing IVF/ICSI cycles are strongly dependent on ovarian reserve and female ageSemantic proximity Read ↗

The Efficacy of PGT-A versus Conventional IVF/ICSI in Infertile Women of Advanced Maternal Age (≥38 Years): A Comparative Analysis of Cumulative Live Birth Rates per Oocyte Retrieval CycleSemantic proximity Read ↗

Genetic Results and Clinical Pregnancy Outcomes Following Preimplantation Genetic Testing: A Retrospective Analysis of 2577 Embryo BiopsiesSemantic proximity Read ↗

Which euploid single embryo transfer strategy is preferable in advanced maternal aged; Fresh versus frozenSemantic proximity Read ↗

Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score designSemantic proximity Read ↗

Assisted reproductive technology ( ART ) cumulative live birth rates following preimplantation genetic diagnosis for aneuploidy ( PGD ‐A) or morphological assessment of embryos: A cohort analysisSemantic proximity Read ↗

Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transferSemantic proximity Read ↗

Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.